What Biotricity Inc's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 0 | 0 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Rosa David A | Director | Nov 29 | Grant / award · A | +27,174 | — | — | 152,174 |
| Betts Norman M. | Director | Nov 29 | Grant / award · A | +54,348 | — | — | 375,598 |
| Rosa David A | Director | Oct 11 | Open-market sale · S | −3,318 | $3.05 | −$10.1K | 125,000 |
| Rosa David A | Director | Oct 08 | Open-market sale · S | −9,481 | $3.20 | −$30.3K | 128,318 |
| Rosa David A | Director | Oct 07 | Open-market sale · S | −17,228 | $3.08 | −$53.1K | 137,799 |
| Rosa David A | Director | Sep 16 | Open-market sale · S | −34,977 | $3.43 | −$120K | 155,027 |
| Rosa David A | Director | Sep 15 | Open-market sale · S | −6,246 | $3.27 | −$20.4K | 190,004 |
| Kennedy Patricia J | Director | Apr 07 | Grant / award · A | +125,000 | — | — | 250,000 |
| Betts Norman M. | Director | Apr 07 | Grant / award · A | +125,000 | — | — | 321,250 |
Loading...